The authors report the use of the cytostatic drug cytosar in the control of herpetic complications in patients with acute leukemia and lymphogranulomatosis. A distinct effect was obtained as a result of intravenous drip of cytosar in a dose of 0.03-0.05 g for 2 days. It is desirable that cytosar therapy may be instituted within the first days of the development of herpetic infection.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
control herpetic
8
herpetic complications
8
complications patients
8
patients acute
8
acute leukemia
8
[use cytosar
4
cytosar cytosine
4
cytosine arabinoside
4
arabinoside control
4
leukemia lymphogranulomatosis]
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!